drugset / Trial / NCT05928936
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
Phase 2
Recruiting
156 enrolled
Emory University
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The goals of this project are to investigate the mechanisms and potential therapies related to exercise capacity in persons with chronic kidney disease (CKD).
Timeline
- Start
- 2022-11-11
- Primary completion
- 2028-06-01
- Completion
- 2028-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 650 mg | Oral |
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 1300 mg | Oral |